Position in TRDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,305,243
-$1,380,039 QoQ
Shares Held
177,343
-16.7% QoQ
Ownership
0.455%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 128 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. TRDA ranks #243 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in TRDA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,305,243 | 177,343 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,685,282 | 212,780 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,109,177 | 205,173 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $1,289,548 | 222,336 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $565,487 | 84,150 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $836,561 | 92,540 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $4,932,352 | 285,272 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,349,766 | 84,466 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $474,553 | 33,302 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $245,466 | 17,323 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $272,585 | 18,064 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $202,303 | 12,804 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $323,027 | 21,336 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $684,052 | 47,176 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $5,435,567 | 402,039 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $7,091,889 | 449,993 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $5,428,455 | 445,686 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $4,182,822 | 445,455 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,626,189 | 445,455 | Shares | Defined | 2022-02-17 | |
| No filing history on record for this holder in this stock. | ||||||